NHS - Neuberger Berman High Yield Strategies Fund Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 147.41M
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.88
Enterprise value/revenue -7.60
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.99
52-week change 3-14.81%
S&P500 52-week change 36.21%
52-week high 39.82
52-week low 37.40
50-day moving average 38.50
200-day moving average 38.50

Share statistics

Avg vol (3-month) 390.92k
Avg vol (10-day) 394.01k
Shares outstanding 519.45M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 10.00%
% held by institutions 128.70%
Shares short (14 May 2023) 4290.06k
Short ratio (14 May 2023) 43.26
Short % of float (14 May 2023) 41.68%
Short % of shares outstanding (14 May 2023) 41.49%
Shares short (prior month 13 Apr 2023) 4227.25k

Dividends & splits

Forward annual dividend rate 41.09
Forward annual dividend yield 414.37%
Trailing annual dividend rate 31.09
Trailing annual dividend yield 314.33%
5-year average dividend yield 49.50
Payout ratio 4N/A
Dividend date 327 Feb 2019
Ex-dividend date 401 Jun 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Oct 2022
Most-recent quarter (mrq)30 Oct 2022


Profit margin -189.61%
Operating margin (ttm)87.28%

Management effectiveness

Return on assets (ttm)3.28%
Return on equity (ttm)-19.17%

Income statement

Revenue (ttm)17.66M
Revenue per share (ttm)0.91
Quarterly revenue growth (yoy)32.40%
Gross profit (ttm)17.66M
Net income avi to common (ttm)-33.49M
Diluted EPS (ttm)-2.29
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)121.89M
Total debt/equity (mrq)72.43
Current ratio (mrq)1.23
Book value per share (mrq)8.66

Cash flow statement

Operating cash flow (ttm)-48.69M
Levered free cash flow (ttm)5.19M